James B. Bucher
Insider Reports History
- Location
- Bothell, WA
- Signature
- /s/ James B. Bucher
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by James B. Bucher:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. | Chief Legal Officer | Stock Option (Right to Buy) | 100,000 | 08 Jan 2026 | Direct | ||
| Eliem Therapeutics, Inc. | EVP and General Counsel | Stock Option (Right to Buy) | 95,000 | 31 Oct 2022 | Direct | ||
| Harpoon Therapeutics, Inc. | Chief Legal Officer | Employee Stock Option (Right to Buy) | 0 | 11 Mar 2024 | Direct |
Insider Reports Filed by James B. Bucher
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | 08 Jan 2026 | 1 | $0 | 4 | Chief Legal Officer | 09 Jan 2026, 20:35 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | 01 Oct 2025 | 1 | $0 | 4 | Chief Legal Officer | 01 Oct 2025, 18:40 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | 18 Sep 2025 | 0 | $0 | 3 | Chief Legal Officer | 22 Sep 2025, 16:10 |
| /report/000095017024029425-bucher-james-b-2024-03-11 | Harpoon Therapeutics, Inc. | 11 Mar 2024 | 1 | $0 | 4 | Chief Legal Officer | 11 Mar 2024, 17:15 |
| /report/000095017023073031-bucher-james-b-2023-12-21 | Harpoon Therapeutics, Inc. | 21 Dec 2023 | 1 | $0 | 4 | Chief Legal Officer | 26 Dec 2023, 16:10 |
| /report/000095017023073023-bucher-james-b-2023-12-21 | Harpoon Therapeutics, Inc. | 21 Dec 2023 | 0 | $0 | 3 | Chief Legal Officer | 26 Dec 2023, 16:05 |
| CLYM | Eliem Therapeutics, Inc. | 31 Oct 2022 | 1 | $0 | 4 | EVP and General Counsel | 02 Nov 2022, 19:06 |
| CLYM | Eliem Therapeutics, Inc. | 27 Jan 2022 | 1 | $0 | 4 | EVP and General Counsel | 31 Jan 2022, 16:06 |
| CLYM | Eliem Therapeutics, Inc. | 09 Aug 2021 | 0 | $0 | 3 | EVP and General Counsel | 09 Aug 2021, 18:13 |